LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
1.140
-0.030 (-2.56%)
May 9, 2025, 3:52 PM - Market open
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $21.75 million as of May 9, 2025. Its market cap has decreased by -86.49% in one year.
Market Cap
21.75M
Enterprise Value
46.99M
1-Year Change
-86.49%
Ranking
Category
Stock Price
1.14
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $21.75M, a decrease of -90.45%. That is a compound annual growth rate of -46.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 22.32M | -66.18% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 349.75B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |